Document is current
Any future updates will be listed below
-
Authors
Zhong, Fangyan
Lu, Tianzhu
Li, Ming
Li, Dangchi
Yuan, Anqi
Luo, Hong
Wang, Jinglun
Zhang, Lin
Huang, Kai
Su, Yong
Chen, Junjun
Dong, Qing
Wang, Jing
Liu, Zhiliang
Huang, Chuansheng
Gong, Xiaochang
Xiong, Xiaopeng
Li, Jingao
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Jiangxi Province (20212BAB216064, 20224BAB216053, 20224BAB206065, 20242BAB25517)
National Natural Science Foundation of China (82103478, 82160710)
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT320-004)
Key Project of Jiangxi Provincial Department of Education (GJJ2203507)
Jiangxi Province Key R&D Program (20232BBG70025)
The “Five-level Progressive” talent cultivation project of Jiangxi Cancer Hospital & Institute (WCDJ2024YQ01)
- License Information
-
More Information
Article History
Received: 21 December 2024
Accepted: 9 September 2025
First Online: 13 October 2025
Declarations
:
: The authors declare no competing interests.
: This study was conducted in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of Jiangxi Cancer Hospital (No. 20220956). Written informed consent was obtained from each patient. All the animal experiments were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals and the Institutional Code of Ethics for Animal Experiments. Ethical approval for the animal research was obtained from Nanchang Royo Biotech Co., Ltd. (approval number: RYE2024031001). All procedures were conducted in full compliance with the ARRIVE guidelines.
: All authors have read and approved of its submission to this journal.
